Individual Study / LIPID study

The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study:
  1. Home
  2. Studies
  3. LIPID study

The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study:

Initiatives -
Start Year
1990
End Year
1997
Funding
NHMRC Clinical Trials Centre, University of Sydney, under the auspices of the National Heart Foundation of Australia.
Add to cart

Members

Download
Investigators Contacts
  • Dr. Peter J. Meikle
    Baker Heart and Diabetes Institute
  • Dr. Prof. Anne Tonkin
    University of Adelaide · School of Medicine

Design

Study design
Clinical trial cohort
Follow Up
A mean follow-up of 6 years

Marker Paper

LIPID Study Group. (2002). Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. The Lancet, 359(9315), 1379-1387.

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
9,014
Number of participants with biosamples
Supplementary Information
Patients were recruited from 87 centres in Australia and New Zealand. Aged 31-75 years.

Access

Availability of data and biosamples

Data
Biosamples
Other
Yes
No
Not applicable
Don't know